Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Preferred Dividend Payments: 2021-2022

Historic Preferred Dividend Payments for Prime Medicine (PRME) over the last 1 years, with Dec 2022 value amounting to $1.3 million.

  • Prime Medicine's Preferred Dividend Payments fell 79.35% to $1.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $20.2 million, marking a year-over-year change of. This contributed to the annual value of $20.2 million for FY2022, which is 16.83% up from last year.
  • As of Q4 2022, Prime Medicine's Preferred Dividend Payments stood at $1.3 million, which was down 79.35% from $6.4 million recorded in Q3 2022.
  • Prime Medicine's 5-year Preferred Dividend Payments high stood at $6.4 million for Q3 2021, and its period low was $1.3 million during Q4 2022.
  • Its 2-year average for Preferred Dividend Payments is $5.5 million, with a median of $6.3 million in 2021.
  • Data for Prime Medicine's Preferred Dividend Payments shows a maximum YoY crashed of 79.35% (in 2022) over the last 5 years.
  • Over the past 2 years, Prime Medicine's Preferred Dividend Payments (Quarterly) stood at $6.4 million in 2021, then crashed by 79.35% to $1.3 million in 2022.
  • Its Preferred Dividend Payments was $1.3 million in Q4 2022, compared to $6.4 million in Q3 2022 and $6.3 million in Q2 2022.